Literature DB >> 8811802

Safety limits for nutrients.

J N Hathcock1.   

Abstract

The occurrence of adverse health effects from ingestion of any substance depends on its inherent toxic potential, the amount of intake, and the biological characteristics of the exposed individual. A safe intake is one that provides an acceptable margin of safety below the intake that carries risk of adverse effects. If appropriate data are available, applying fixed safety factors, systematically varying safety factors or using other methods to identify reasonable limits for safe intakes. A crucial factor in understanding the margin of safety that a particular intake is likely to provide is the adequacy of the data to estimate the likely frequency of the adverse response among persons with that intake. For a few nutrients there are sufficient numbers of reports of adverse effects over a sufficiently wide range of exposures to allow estimation of lowest adverse effect levels; for other nutrients the reports of adverse effects are too infrequent or inconsistent to support estimations that are meaningful.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811802     DOI: 10.1093/jn/126.suppl_9.2386S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  5 in total

1.  Anti-atherogenic effect of trivalent chromium-loaded CPMV nanoparticles in human aortic smooth muscle cells under hyperglycemic conditions in vitro.

Authors:  Rituparna Ganguly; Amy M Wen; Ashley B Myer; Tori Czech; Soumyadip Sahu; Nicole F Steinmetz; Priya Raman
Journal:  Nanoscale       Date:  2016-03-28       Impact factor: 7.790

2.  Severe insulin resistance treatment with intravenous chromium in septic shock patient.

Authors:  Salim R Surani; Iqbal Ratnani; Bharath Guntupalli; Swetha Bopparaju
Journal:  World J Diabetes       Date:  2012-09-15

Review 3.  The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent.

Authors:  John B Vincent
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

4.  Oral chromium picolinate impedes hyperglycemia-induced atherosclerosis and inhibits proatherogenic protein TSP-1 expression in STZ-induced type 1 diabetic ApoE-/- mice.

Authors:  Rituparna Ganguly; Soumyadip Sahu; Vahagn Ohanyan; Rebecca Haney; Ronaldo J Chavez; Shivani Shah; Siri Yalamanchili; Priya Raman
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

5.  Rationale and design of an international randomized placebo-controlled trial of a 36-ingredient micronutrient supplement for children with ADHD and irritable mood: The Micronutrients for ADHD in Youth (MADDY) study.

Authors:  Jeanette M Johnstone; Brenda Leung; Barbara Gracious; Leanna Perez; Gabriella Tost; Andrew Savoy; Irene Hatsu; Andrew Hughes; Alisha Bruton; L Eugene Arnold
Journal:  Contemp Clin Trials Commun       Date:  2019-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.